105 related articles for article (PubMed ID: 27528360)
1. Malignant Glioma In Vitro Models: On the Utilization of Stem-like Cells.
Balvers RK; Dirven CM; Leenstra S; Lamfers ML
Curr Cancer Drug Targets; 2017; 17(3):255-266. PubMed ID: 27528360
[TBL] [Abstract][Full Text] [Related]
2. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
3. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
4. Isolation and Propagation of Glioma Stem Cells from Acutely Resected Tumors.
Jung J; Gilbert MR; Park DM
Methods Mol Biol; 2016; 1516():361-369. PubMed ID: 27044042
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
6. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
7. S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma.
Chow KH; Park HJ; George J; Yamamoto K; Gallup AD; Graber JH; Chen Y; Jiang W; Steindler DA; Neilson EG; Kim BYS; Yun K
Cancer Res; 2017 Oct; 77(19):5360-5373. PubMed ID: 28807938
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
[TBL] [Abstract][Full Text] [Related]
9. The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma.
Aderetti DA; Hira VVV; Molenaar RJ; van Noorden CJF
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):346-354. PubMed ID: 29684521
[TBL] [Abstract][Full Text] [Related]
10. Enrichment of glioma stem cell-like cells on 3D porous scaffolds composed of different extracellular matrix.
Wang X; Dai X; Zhang X; Li X; Xu T; Lan Q
Biochem Biophys Res Commun; 2018 Apr; 498(4):1052-1057. PubMed ID: 29551682
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of glioma stem cells.
Sampetrean O; Saya H
Brain Tumor Pathol; 2013 Oct; 30(4):209-14. PubMed ID: 23584571
[TBL] [Abstract][Full Text] [Related]
12. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
13. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
14. The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells.
Kim SH; Kim EJ; Hitomi M; Oh SY; Jin X; Jeon HM; Beck S; Jin X; Kim JK; Park CG; Chang SY; Yin J; Kim T; Jeon YJ; Song J; Lim YC; Lathia JD; Nakano I; Kim H
Cell Death Differ; 2015 Sep; 22(9):1517-25. PubMed ID: 25721045
[TBL] [Abstract][Full Text] [Related]
15. The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.
Auffinger B; Spencer D; Pytel P; Ahmed AU; Lesniak MS
Expert Rev Neurother; 2015; 15(7):741-52. PubMed ID: 26027432
[TBL] [Abstract][Full Text] [Related]
16. HIF1α regulates single differentiated glioma cell dedifferentiation to stem-like cell phenotypes with high tumorigenic potential under hypoxia.
Wang P; Lan C; Xiong S; Zhao X; Shan Y; Hu R; Wan W; Yu S; Liao B; Li G; Wang J; Zou D; Chen B; Feng H; Wu N
Oncotarget; 2017 Apr; 8(17):28074-28092. PubMed ID: 28427209
[TBL] [Abstract][Full Text] [Related]
17. Antitumorigenic effect of interferon-β by inhibition of undifferentiated glioblastoma cells.
Yamamuro S; Sano E; Okamoto Y; Ochiai Y; Ohta T; Ogino A; Natsume A; Wakabayashi T; Ueda T; Hara H; Nakayama T; Yoshino A; Katayama Y
Int J Oncol; 2015 Nov; 47(5):1647-54. PubMed ID: 26397698
[TBL] [Abstract][Full Text] [Related]
18. Correlation between low-level expression of the tumor suppressor gene TAp73 and the chemoresistance of human glioma stem cells.
Hu X; Wu N; Xia P; Yu S; Sun F; Chen J
Cancer Chemother Pharmacol; 2012 May; 69(5):1205-12. PubMed ID: 22258403
[TBL] [Abstract][Full Text] [Related]
19. IGFBP2 promotes glioma tumor stem cell expansion and survival.
Hsieh D; Hsieh A; Stea B; Ellsworth R
Biochem Biophys Res Commun; 2010 Jun; 397(2):367-72. PubMed ID: 20515648
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonic Surgical Aspirate is a Reliable Source For Culturing Glioblastoma Stem Cells.
Behnan J; Stangeland B; Langella T; Finocchiaro G; Murrell W; Brinchmann JE
Sci Rep; 2016 Sep; 6():32788. PubMed ID: 27605047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]